A

Arbutus Biopharma Corp
D

ABUS

3.21500
USD
0.02
(0.47%)
مغلق
حجم التداول
18,224
الربح لكل سهم
-0
العائد الربحي
-
P/E
-8
حجم السوق
615,759,720
أصول ذات صلة
ALNY
ALNY
0.47
(0.16%)
289.82 USD
A
ARCT
-0.620
(-4.84%)
12.190 USD
BNTX
BNTX
-0.380
(-0.38%)
98.700 USD
D
DVAX
-0.02000
(-0.20%)
9.79500 USD
GILD
GILD
0.670
(0.63%)
107.390 USD
MRNA
MRNA
-0.820
(-3.03%)
26.280 USD
V
VKTX
-0.715
(-2.58%)
26.985 USD
V
VRNA
2.460
(3.39%)
75.080 USD
المزيد
الأخبار المقالات

العنوان: Arbutus Biopharma Corp

القطاع: Healthcare
الصناعة: Biotechnology
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.